In a client update on Thursday, Mackie Research analyst André Uddin has changed his rating for biot... Read More
An Alzheimer’s drug trial failure has caused Mackie Research analyst André Uddin to downgrade his... Read More
In an update to clients on Wednesday, Mackie Research analyst André Uddin gives a review of Promis ... Read More